Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 134th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
INSM	INSMED INC	$37.29B	-183.60%	-54.60%	-56.31%	-53.90%	1.50	4.63	76.50%	-264.80%	-244.81%
NBY	NOVABAY PHARMACEUTICALS INC	$667.86M	113.90%	54.80%	159.05%	529.50%	1.67	2.00	54.60%	114.60%	114.59%
JANX	JANUX THERAPEUTICS INC	$829.44M	-10.20%	-9.80%	-10.22%	-11.40%	0.05	35.86	100.00%	-1,019.00%	-1,018.95%
UPB	UPSTREAM BIO INC	$1.59B	-28.80%	-28.10%	-32.23%	-40.80%	0.03	32.67	100.00%	-4,386.40%	-4,366.77%
XNCR	XENCOR INC	$1.11B	-20.40%	-14.50%	-12.25%	-9.80%	0.39	6.00	100.00%	-87.10%	-63.85%
CYPH	CYPHERPUNK TECHNOLOGIES INC	$73.65M	-316.10%	-176.10%	-1,881.63%	435.00%	3.23	1.21	N/A	N/A	N/A
PHAT	PHATHOM PHARMACEUTICALS INC	$1.25B	N/A	-94.40%	-138.80%	-37.00%	-1.57	2.23	87.20%	-186.50%	-138.77%
CGEN	COMPUGEN LTD	$142.18M	-53.60%	-25.40%	-35.53%	-123.40%	1.23	4.38	7.40%	-400.10%	-399.26%
PLX	PROTALIX BIOTHERAPEUTICS INC	$139.13M	11.30%	7.00%	12.37%	18.00%	0.56	3.03	57.50%	8.70%	12.06%
BBIO	BRIDGEBIO PHARMA INC	$14.70B	N/A	-82.20%	-86.24%	-30.80%	-1.51	3.88	95.80%	-225.30%	-190.53%
OKYO	OKYO PHARMA LTD	$76.35M	N/A	-180.40%	127.79%	102.70%	-1.66	0.40	N/A	N/A	N/A
SLGL	SOL-GEL TECHNOLOGIES LTD	$117.45M	N/A	N/A	N/A	N/A	0.33	5.15	N/A	N/A	N/A
IVA	INVENTIVA SA	$402.74M	N/A	-284.90%	-93.27%	-121.40%	-21.09	2.96	100.00%	-1,767.30%	-638.55%
LBRX	LB PHARMACEUTICALS INC	$533.05M	N/A	N/A	N/A	N/A	0.03	47.60	N/A	N/A	N/A
GLTO	GALECTO INC	$36.06M	-130.70%	-111.30%	-195.32%	-1,211.70%	0.34	3.73	N/A	N/A	N/A
NUVB	NUVATION BIO INC	$3.24B	-55.00%	-38.10%	-39.44%	-42.00%	0.85	8.48	54.30%	-813.10%	-786.53%
UNCY	UNICYCIVE THERAPEUTICS INC	$119.49M	-184.40%	-95.50%	-89.14%	368.10%	0.35	3.83	N/A	N/A	N/A
TTRX	TURN THERAPEUTICS INC	$88.34M	N/A	N/A	N/A	N/A	7.53	1.43	N/A	N/A	N/A
MDGL	MADRIGAL PHARMACEUTICALS INC	$13.42B	-41.50%	-26.20%	-27.97%	-32.00%	1.18	3.44	95.30%	-39.00%	-36.67%
CAMP	CAMP4 THERAPEUTICS CORP	$299.10M	-100.10%	-76.60%	-68.03%	-490.20%	0.47	9.83	100.00%	-1,404.50%	-1,404.47%
IONS	IONIS PHARMACEUTICALS INC	$12.89B	-44.30%	-8.70%	-7.89%	-4.80%	3.91	2.79	98.80%	-26.50%	-17.37%
KURA	KURA ONCOLOGY INC	$856.25M	-65.40%	-30.60%	-40.35%	-41.40%	1.68	5.12	100.00%	-208.50%	-204.82%
NVO	NOVO NORDISK A S	$213.69B	67.00%	21.30%	47.46%	56.40%	2.02	0.78	82.00%	32.90%	41.80%
LEGN	LEGEND BIOTECH CORP	$4.05B	-23.40%	-14.30%	-15.74%	-27.80%	0.69	2.87	60.60%	-26.40%	-22.16%
DARE	DARE BIOSCIENCE INC	$29.86M	N/A	-82.70%	-183.21%	165.90%	9.76	1.18	-44.70%	30,568.80%	30,568.80%
PVLA	PALVELLA THERAPEUTICS INC	$1.18B	-68.50%	-45.50%	-49.43%	433.60%	0.73	6.49	100.00%	66,162.30%	52,807.55%
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$948.72M	-32.10%	-28.20%	-31.77%	-35.90%	0.14	8.68	89.40%	-113.50%	-108.69%
ATNM	ACTINIUM PHARMACEUTICALS INC	$52.72M	-151.70%	-52.30%	-70.16%	1,172.70%	3.07	7.96	100.00%	-38,443.30%	-38,443.33%
ADMA	ADMA BIOLOGICS INC	$4.66B	54.00%	39.40%	32.05%	35.70%	0.32	7.13	54.70%	42.90%	33.60%
URGN	UROGEN PHARMA LTD	$1.07B	N/A	-71.00%	-102.36%	-74.20%	-2.60	3.99	88.00%	-170.60%	-151.45%
FGEN	FIBROGEN INC	$34.79M	-126.40%	124.20%	213.12%	161.40%	-7.02	3.71	82.70%	-182.60%	-182.34%
CRVS	CORVUS PHARMACEUTICALS INC	$559.37M	-25.80%	-20.20%	-20.82%	-28.70%	0.12	8.29	N/A	N/A	N/A
SLS	SELLAS LIFE SCIENCES GROUP INC	$336.16M	-95.20%	-75.10%	-56.85%	1,520.90%	0.13	8.28	N/A	N/A	N/A
HRTX	HERON THERAPEUTICS INC	$238.37M	N/A	-5.70%	-6.97%	-4.50%	15.73	2.56	73.90%	-8.80%	-7.15%
RAPT	RAPT THERAPEUTICS INC	$936.90M	-61.80%	-54.70%	-69.33%	-107.60%	0.09	12.04	N/A	N/A	N/A
SEER	SEER INC	$99.86M	-26.50%	-23.60%	-26.94%	-26.10%	0.14	14.25	50.70%	-484.50%	-482.85%
ABUS	ARBUTUS BIOPHARMA CORP	$852.00M	-50.20%	-37.60%	-45.57%	-57.70%	0.26	18.80	100.00%	-289.40%	-288.70%
TCRX	TSCAN THERAPEUTICS INC	$50.85M	-73.90%	-45.10%	-59.97%	-67.10%	0.82	6.44	100.00%	-1,693.00%	-1,659.11%
XLO	XILIO THERAPEUTICS INC	$35.12M	-857.90%	-52.90%	-75.67%	265.00%	-17.52	2.20	100.00%	-183.90%	-183.90%
NXTC	NEXTCURE INC	$30.50M	-132.90%	-98.60%	-202.71%	-149.10%	0.68	2.97	N/A	N/A	N/A
HYFT	MINDWALK HOLDINGS CORP	$77.08M	-136.90%	-76.10%	-155.54%	-149.70%	0.47	4.19	58.50%	-146.10%	-159.30%
DBVT	DBV TECHNOLOGIES SA	$769.81M	-295.60%	-135.20%	-204.90%	-4,670.60%	1.09	1.80	100.00%	-2,273.90%	-2,271.65%
VTYX	VENTYX BIOSCIENCES INC	$623.67M	-48.10%	-43.90%	-53.25%	-50.70%	0.11	17.86	N/A	N/A	N/A
PLRZ	POLYRIZON LTD	$9.24M	-12.40%	-11.70%	-18.72%	-3,440.00%	0.02	44.04	N/A	N/A	N/A
CGTX	COGNITION THERAPEUTICS INC	$135.94M	-150.10%	-95.90%	-76.14%	728.50%	0.19	6.45	N/A	N/A	N/A
ZNTL	ZENTALIS PHARMACEUTICALS INC	$101.15M	-51.50%	-40.00%	-51.54%	-45.80%	0.29	7.76	100.00%	368.10%	368.64%
ALT	ALTIMMUNE INC	$406.59M	-54.80%	-47.60%	-40.73%	-92.80%	0.18	17.18	100.00%	-559,433.30%	-558,900.00%
ERAS	ERASCA INC	$978.81M	-33.10%	-27.80%	-32.60%	-31.00%	0.21	10.45	N/A	N/A	N/A
IBRX	IMMUNITYBIO INC	$2.05B	N/A	-86.70%	-48.87%	-21.30%	-1.99	5.77	99.60%	-422.30%	-273.40%
JBIO	JADE BIOSCIENCES INC	$783.45M	-49.00%	-44.70%	-36.20%	-139.20%	0.13	9.01	N/A	N/A	N/A
TLSA	TIZIANA LIFE SCIENCES LTD	$169.42M	-250.50%	-101.10%	-425.46%	-666.20%	1.87	1.02	N/A	N/A	N/A
ACOG	ALPHA COGNITION INC	$120.89M	-52.60%	-40.80%	-50.11%	-1,606.00%	0.37	6.69	73.10%	-262.20%	-266.30%
ACIU	AC IMMUNE SA	$305.71M	-83.50%	-35.80%	-97.78%	-248.70%	1.75	1.16	100.00%	-1,643.90%	-1,639.75%
ALLR	ALLARITY THERAPEUTICS INC	$16.29M	-112.00%	-64.90%	-125.80%	277.30%	0.73	2.33	N/A	N/A	N/A
PBM	PSYENCE BIOMEDICAL LTD	$1.87M	N/A	N/A	N/A	N/A	0.08	8.09	N/A	N/A	N/A
CVAC	CUREVAC NV	$939.36M	18.40%	15.30%	18.22%	52.50%	0.31	3.70	93.00%	182.10%	232.41%
MGX	METAGENOMI INC	$66.08M	-43.20%	-31.10%	-41.23%	-34.60%	0.39	6.42	100.00%	-287.10%	-291.26%
PASG	PASSAGE BIO INC	$30.48M	-102.10%	-53.00%	-87.19%	-120.00%	1.38	2.51	N/A	N/A	N/A
NCNA	NUCANA PLC	$0.00	-253.40%	-147.00%	-61.57%	750.70%	0.25	4.76	N/A	N/A	N/A
ALDX	ALDEYRA THERAPEUTICS INC	$298.41M	-72.20%	-47.90%	-83.73%	-130.90%	0.58	2.72	N/A	N/A	N/A
MREO	MEREO BIOPHARMA GROUP PLC	$318.26M	-75.00%	-63.70%	-90.19%	3,290.60%	0.15	8.71	73.60%	-8,314.60%	-8,583.60%
KZR	KEZAR LIFE SCIENCES INC	$46.43M	-62.50%	-51.80%	-71.92%	-77.80%	0.18	7.07	N/A	N/A	N/A
RANI	RANI THERAPEUTICS HOLDINGS INC	$183.48M	N/A	-129.00%	273.69%	-132.60%	-2.81	0.26	100.00%	-2,359.60%	-2,053.83%
EDIT	EDITAS MEDICINE INC	$228.43M	-348.50%	-78.60%	-143.62%	-160.90%	14.00	2.86	100.00%	-430.80%	-433.42%
COEP	COEPTIS THERAPEUTICS HOLDINGS INC	$78.29M	-172.70%	-92.60%	-95.84%	-192.70%	0.32	2.21	73.00%	-2,251.50%	-2,195.46%
ALGS	ALIGOS THERAPEUTICS INC	$65.72M	-132.40%	-74.30%	-84.18%	-123.30%	0.53	4.70	100.00%	-3,267.60%	-2,792.71%
COYA	COYA THERAPEUTICS INC	$114.88M	-57.40%	-49.70%	-67.50%	-49,060.60%	0.17	8.73	100.00%	-462.30%	-480.32%
PRTA	PROTHENA CORP PUBLIC LTD CO	$495.77M	-72.70%	-62.50%	-79.27%	-3,639.10%	0.20	6.61	100.00%	-2,379.60%	-2,025.72%
OCGN	OCUGEN INC	$437.25M	-491.20%	-99.20%	-163.12%	-157.50%	15.30	1.85	100.00%	-1,192.20%	-1,131.02%
TNYA	TENAYA THERAPEUTICS INC	$116.72M	-95.50%	-76.80%	-102.71%	-122.30%	0.27	4.64	N/A	N/A	N/A
GALT	GALECTIN THERAPEUTICS INC	$282.39M	N/A	-269.90%	24.43%	-70.60%	-1.09	0.09	N/A	N/A	N/A
QTTB	Q32 BIO INC	$36.42M	N/A	-57.00%	-90.15%	-269.00%	-4.13	4.57	N/A	N/A	N/A
PSTV	PLUS THERAPEUTICS INC	$78.33M	N/A	-172.50%	-334.59%	276.00%	2.69	1.29	100.00%	-391.30%	-321.61%
MLYS	MINERALYS THERAPEUTICS INC	$2.91B	-48.20%	-45.80%	-29.73%	-83.20%	0.04	25.50	N/A	N/A	N/A
SYRE	SPYRE THERAPEUTICS INC	$2.59B	-31.20%	-26.80%	-32.51%	-35.40%	0.11	10.91	N/A	N/A	N/A
TRVI	TREVI THERAPEUTICS INC	$1.67B	-31.20%	-29.30%	-24.11%	-50.10%	0.05	21.93	N/A	N/A	N/A
PEPG	PEPGEN INC	$372.62M	-84.10%	-65.60%	-53.08%	-125.70%	0.17	13.15	N/A	N/A	N/A
CNTA	CENTESSA PHARMACEUTICALS PLC	$3.34B	-67.70%	-47.50%	-54.43%	-51.00%	0.49	10.57	100.00%	-1,618.00%	-1,521.18%
EVMN	EVOMMUNE INC	$575.31M	N/A	N/A	N/A	N/A	-0.06	7.87	N/A	N/A	N/A
GERN	GERON CORP	$849.01M	-30.30%	-14.00%	-9.57%	-6.90%	1.28	5.96	97.70%	-43.60%	-25.04%
EQ	EQUILLIUM INC	$70.03M	-148.80%	-109.40%	-76.58%	1,073.10%	0.12	10.85	100.00%	-555.90%	-547.72%
ZLAB	ZAI LAB LTD	$2.00B	-25.80%	-17.70%	-25.28%	-96.60%	0.53	2.87	61.30%	-46.80%	-45.75%
ZBIO	ZENAS BIOPHARMA INC	$1.94B	-73.50%	-57.60%	-70.35%	-174.50%	0.64	5.66	100.00%	-1,266.00%	-1,264.37%
ACTU	ACTUATE THERAPEUTICS INC	$162.24M	-2,924.50%	-250.70%	-212.50%	311.00%	0.62	2.74	N/A	N/A	N/A
VYGR	VOYAGER THERAPEUTICS INC	$222.40M	-48.90%	-37.40%	-49.86%	-45.70%	0.31	6.19	100.00%	-404.80%	-402.55%
ANRO	ALTO NEUROSCIENCE INC	$620.71M	-47.40%	-38.10%	-43.51%	-245.30%	0.32	15.42	N/A	N/A	N/A
CMPX	COMPASS THERAPEUTICS INC	$887.53M	-48.90%	-42.50%	-30.07%	-58.90%	0.10	17.82	N/A	N/A	N/A
ALMS	ALUMIS INC	$1.18B	-75.50%	-57.60%	-60.04%	-105.60%	0.27	6.01	100.00%	-1,108.20%	-1,146.94%
OCS	OCULIS HOLDING AG	$1.19B	-81.70%	-61.80%	-77.18%	-150.90%	0.29	4.47	100.00%	-36,145.10%	-35,938.25%
NAMS	NEWAMSTERDAM PHARMA CO NV	$3.98B	-29.10%	-26.90%	-30.36%	-211.70%	0.08	12.57	100.00%	-627.30%	-627.28%
MBX	MBX BIOSCIENCES INC	$1.37B	-29.30%	-28.10%	-20.75%	-42.40%	0.03	32.96	N/A	N/A	N/A
FATE	FATE THERAPEUTICS INC	$121.12M	-56.60%	-40.20%	-49.47%	-40.10%	0.47	7.87	100.00%	-2,187.10%	-2,187.11%
BNTC	BENITEC BIOPHARMA INC	$389.42M	-45.90%	-44.00%	-41.64%	2,647.30%	0.03	46.95	N/A	N/A	N/A
CRBU	CARIBOU BIOSCIENCES INC	$157.03M	-80.80%	-62.70%	-94.14%	-69.20%	0.38	5.54	100.00%	-1,690.40%	-1,690.54%
STOK	STOKE THERAPEUTICS INC	$1.83B	13.30%	11.40%	8.62%	16.40%	0.17	6.53	100.00%	19.70%	13.35%
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$201.26M	-55.20%	-49.90%	-42.88%	-210.80%	0.09	9.89	34.30%	-963.40%	-963.38%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$245.03M	-33.30%	-28.40%	-32.73%	-29.60%	0.19	14.96	N/A	N/A	N/A
SVRA	SAVARA INC	$1.23B	-86.60%	-65.40%	-93.14%	-66.40%	0.49	7.65	N/A	N/A	N/A
FULC	FULCRUM THERAPEUTICS INC	$664.57M	-32.20%	-30.00%	-34.99%	-38.20%	0.08	17.70	N/A	N/A	N/A
SPRB	SPRUCE BIOSCIENCES INC	$84.28M	-305.40%	-168.00%	-762.62%	955.90%	1.84	1.54	100.00%	-6,869.30%	-6,440.17%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Alnylam Pharmaceuticals (NASDAQ:ALNY)

Alnylam Pharmaceuticals (NASDAQ:ALNY) is the #1 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Alnylam Pharmaceuticals (NASDAQ:ALNY) is: Value: C, Growth: A, Momentum: C, Sentiment: A, Safety: D, Financials: B, and AI: B.

Alnylam Pharmaceuticals (NASDAQ:ALNY) has a Due Diligence Score of 45, which is 22 points higher than the biotech industry average of 23.

ALNY passed 16 out of 33 due diligence checks and has strong fundamentals. Alnylam Pharmaceuticals has seen its stock return 67.55% over the past year, overperforming other biotech stocks by 108 percentage points.

Alnylam Pharmaceuticals has an average 1 year price target of $491.28, an upside of 22.75% from Alnylam Pharmaceuticals's current stock price of $400.23.

Alnylam Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 25 analysts covering Alnylam Pharmaceuticals, 48% have issued a Strong Buy rating, 36% have issued a Buy, 16% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the #2 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Innoviva (NASDAQ:INVA) is: Value: A, Growth: C, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Innoviva (NASDAQ:INVA) has a Due Diligence Score of 45, which is 22 points higher than the biotech industry average of 23.

INVA passed 14 out of 33 due diligence checks and has strong fundamentals. Innoviva has seen its stock return 11.49% over the past year, overperforming other biotech stocks by 52 percentage points.

Innoviva has an average 1 year price target of $32.25, an upside of 61.33% from Innoviva's current stock price of $19.99.

Innoviva stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Innoviva, 25% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 25% have issued a Strong Sell.

3. Beone Medicines (NASDAQ:ONC)

Beone Medicines (NASDAQ:ONC) is the #3 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: C, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 53, which is 30 points higher than the biotech industry average of 23.

ONC passed 18 out of 33 due diligence checks and has strong fundamentals. Beone Medicines has seen its stock return 80.89% over the past year, overperforming other biotech stocks by 121 percentage points.

Beone Medicines has an average 1 year price target of $390.88, an upside of 23.68% from Beone Medicines's current stock price of $316.05.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Beone Medicines, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 11.79%, which is 9 percentage points higher than the biotech industry average of 2.89%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.28%, which is -1 percentage points lower than the biotech industry average of 2.89%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)

Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.55%, which is -2 percentage points lower than the biotech industry average of 2.89%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 64% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.35% in the last day, and down -0.7% over the last week. Cypherpunk Technologies was the among the top gainers in the biotechnology industry, gaining 39.04% yesterday.

Cypherpunk Technologies shares are trading higher after the company announced the appointment of Electric Coin Company CEO Josh Swihart as its Strategic Advisor.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 11.57% in the past year. It has overperformed other stocks in the biotech industry by 52 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 102.52% in the past year. It has overperformed other stocks in the biotech industry by 143 percentage points.

3. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has gained 11.49% in the past year. It has overperformed other stocks in the biotech industry by 52 percentage points.

Are biotech stocks a good buy now?

60.86% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 50.11% over the next year.

3.51% of biotech stocks have a Zen Rating of A (Strong Buy), 6.39% of biotech stocks are rated B (Buy), 46.19% are rated C (Hold), 31.13% are rated D (Sell), and 12.78% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 156.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Alnylam Pharmaceuticals (NASDAQ:ALNY)

2. Innoviva (NASDAQ:INVA)

3. Beone Medicines (NASDAQ:ONC)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Innoviva (NASDAQ:INVA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Alnylam Pharmaceuticals (NASDAQ:ALNY)

2. Innoviva (NASDAQ:INVA)

3. Beone Medicines (NASDAQ:ONC)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Innoviva (NASDAQ:INVA)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.